Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) kicked off on Monday, down -3.31% from the previous trading day, before settling in for the closing price of $42.24. Over the past 52 weeks, AMPH has traded in a range of $36.56-$65.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 17.24% over the last five years. While this was happening, its average annual earnings per share was recorded 17.16%. With a float of $35.79 million, this company’s outstanding shares have now reached $48.37 million.
The firm has a total of 1761 workers. Let’s measure their productivity. In terms of profitability, gross margin is 51.98%, operating margin of 29.71%, and the pretax margin is 25.95%.
Amphastar Pharmaceuticals Inc (AMPH) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Amphastar Pharmaceuticals Inc is 25.56%, while institutional ownership is 74.86%. The most recent insider transaction that took place on Dec 13 ’24, was worth 361,840. In this transaction SENIOR EVP, PRODUCTION CENTER of this company sold 8,000 shares at a rate of $45.23, taking the stock ownership to the 118,469 shares. Before that another transaction happened on Dec 12 ’24, when Company’s SENIOR EVP, PRODUCTION CENTER sold 7,000 for $44.42, making the entire transaction worth $310,975. This insider now owns 118,469 shares in total.
Amphastar Pharmaceuticals Inc (AMPH) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 17.16% per share during the next fiscal year.
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Trading Performance Indicators
Take a look at Amphastar Pharmaceuticals Inc’s (AMPH) current performance indicators. Last quarter, stock had a quick ratio of 2.61. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.58. Likewise, its price to free cash flow for the trailing twelve months is 10.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.01, a number that is poised to hit 0.96 in the next quarter and is forecasted to reach 4.24 in one year’s time.
Technical Analysis of Amphastar Pharmaceuticals Inc (AMPH)
Analysing the last 5-days average volume posted by the [Amphastar Pharmaceuticals Inc, AMPH], we can find that recorded value of 0.57 million was better than the volume posted last year of 0.4 million. As of the previous 9 days, the stock’s Stochastic %D was 18.14%. Additionally, its Average True Range was 1.47.
During the past 100 days, Amphastar Pharmaceuticals Inc’s (AMPH) raw stochastic average was set at 15.58%, which indicates a significant increase from 2.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.15% in the past 14 days, which was lower than the 44.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $47.05, while its 200-day Moving Average is $44.02. Now, the first resistance to watch is $41.98. This is followed by the second major resistance level at $43.13. The third major resistance level sits at $43.76. If the price goes on to break the first support level at $40.20, it is likely to go to the next support level at $39.57. Should the price break the second support level, the third support level stands at $38.42.
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Key Stats
The company with the Market Capitalisation of 1.86 billion has total of 48,081K Shares Outstanding. Its annual sales at the moment are 644,400 K in contrast with the sum of 137,550 K annual income. Company’s last quarter sales were recorded 191,210 K and last quarter income was 40,430 K.
